Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia
S Fuchs, R Baffour, YF Zhou, M Shou, A Pierre… - Journal of the American …, 2001 - jacc.org
OBJECTIVES We tested the hypothesis that intramyocardial injection of autologous bone
marrow (ABM) promotes collateral development in ischemic porcine myocardium. We also …
marrow (ABM) promotes collateral development in ischemic porcine myocardium. We also …
Safety and efficacy of semorinemab in individuals with prodromal to mild Alzheimer disease: a randomized clinical trial
E Teng, PT Manser, K Pickthorn, F Brunstein… - JAMA …, 2022 - jamanetwork.com
Importance Neurofibrillary tangles composed of aggregated tau protein are one of the
neuropathological hallmarks of Alzheimer disease (AD) and correlate with clinical disease …
neuropathological hallmarks of Alzheimer disease (AD) and correlate with clinical disease …
[HTML][HTML] Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers
O Hanon, JS Vidal, S Lehmann, S Bombois… - Alzheimer's & …, 2018 - Elsevier
Introduction Diagnostic relevance of plasma amyloid β (Aβ) for Alzheimer's disease (AD)
process yields conflicting results. The objective of the study was to assess plasma levels of …
process yields conflicting results. The objective of the study was to assess plasma levels of …
[HTML][HTML] Cortical thickness in dementia with Lewy bodies and Alzheimer's disease: a comparison of prodromal and dementia stages
F Blanc, SJ Colloby, N Philippi, X de Petigny, B Jung… - PloS one, 2015 - journals.plos.org
Objectives To assess and compare cortical thickness (CTh) of patients with prodromal
Dementia with Lewy bodies (pro-DLB), prodromal Alzheimer's disease (pro-AD), DLB …
Dementia with Lewy bodies (pro-DLB), prodromal Alzheimer's disease (pro-AD), DLB …
Association of plasma p-tau181 and p-tau231 concentrations with cognitive decline in patients with probable dementia with lewy bodies
MC Gonzalez, NJ Ashton, BF Gomes… - JAMA …, 2022 - jamanetwork.com
Importance Plasma phosphorylated tau (p-tau) has proven to be an accurate biomarker for
Alzheimer disease (AD) pathologic characteristics, offering a less expensive and less …
Alzheimer disease (AD) pathologic characteristics, offering a less expensive and less …
Electromagnetic guidance for catheter-based transendocardial injection: a platform for intramyocardial angiogenesis therapy: results in normal and ischemic porcine …
R Kornowski, MB Leon, S Fuchs, Y Vodovotz… - Journal of the American …, 2000 - jacc.org
OBJECTIVES To test the feasibility of myocardial angiogenic gene expression using a novel
catheter-based transendocardial injection system. BACKGROUND Angiogenesis has been …
catheter-based transendocardial injection system. BACKGROUND Angiogenesis has been …
[HTML][HTML] Insular atrophy at the prodromal stage of dementia with Lewy bodies: a VBM DARTEL study
Diffuse atrophy including the insula was previously demonstrated in dementia with Lewy
bodies (DLB) patients but little is known about the prodromal stage of DLB (pro-DLB). In this …
bodies (DLB) patients but little is known about the prodromal stage of DLB (pro-DLB). In this …
[HTML][HTML] Changes in gray matter volume and functional connectivity in dementia with Lewy bodies compared to Alzheimer's disease and normal aging: implications for …
E Chabran, V Noblet, P Loureiro de Sousa… - Alzheimer's research & …, 2020 - Springer
Background Fluctuations are one of the core clinical features characterizing dementia with
Lewy bodies (DLB). They represent a determining factor for its diagnosis and strongly impact …
Lewy bodies (DLB). They represent a determining factor for its diagnosis and strongly impact …
Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer's disease at the prodromal stage
O Bousiges, S Bombois, S Schraen… - Journal of Neurology …, 2018 - jnnp.bmj.com
Background Differential diagnosis between dementia with Lewy bodies (DLB) and
Alzheimer's disease (AD) is not straightforward, especially in the early stages of disease. We …
Alzheimer's disease (AD) is not straightforward, especially in the early stages of disease. We …
[HTML][HTML] Differential diagnostic value of total alpha-synuclein assay in the cerebrospinal fluid between Alzheimer's disease and dementia with Lewy bodies from the …
O Bousiges, N Philippi, T Lavaux… - Alzheimer's Research & …, 2020 - Springer
Background Several studies have investigated the value of alpha-synuclein assay in the
cerebrospinal fluid (CSF) of Alzheimer's disease (AD) and dementia with Lewy bodies (DLB) …
cerebrospinal fluid (CSF) of Alzheimer's disease (AD) and dementia with Lewy bodies (DLB) …